Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emily A Kaip
Observed names:
E Kaip,
Emily A. Kaip
Institution:
University of California San Francisco Medical Center
Observed institutions:
University of California, San Francisco,
University of California San Francisco Medical Center
OpenAlex ID:
A5058474589
Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomes
2023
·
Amer El Ghali
, Taylor Morrisette
, et al.
·
Antimicrobial Agents and Chemotherapy
·
36
[Raised renin stimulation following orthostasis in unstable or marginal hypertension].
1972
·
C Werning
, N Fischer
, et al.
·
PubMed
·
12
Antiretroviral Therapy Efficacy Post-Bariatric Weight Loss Surgery: A Case Series of Persons Living with Human Immunodeficiency Virus
2022
·
Emily A. Kaip
, Nicole Y. Nguyen
, et al.
·
Obesity Surgery
·
10
PDF
Clinical Evaluation of Omadacycline for Pulmonary Mycobacterium abscessus Complex Infections
2026
·
Mohammed Al Musawa
, Amer El Ghali
, et al.
·
CHEST Pulmonary
·
1
144. Antifungal Use Trends in Hospitalized Adults in the United States, 2016-2020
2021
·
Emily A Kaip
, Ernie Shippey
, et al.
·
Open Forum Infectious Diseases
·
1
646. Clinical and microbiological outcomes of omadacycline for pulmonary Mycobacterium abscessus complex
2025
·
Mohammed Al Musawa
, Raaga Vemula
, et al.
·
Open Forum Infectious Diseases
PDF
2734. Evaluation of Empiric Antimicrobial Therapy for End-Stage Liver Disease Patients at an Academic Medical Center
2023
·
Annie Kim
, Emily A Kaip
, et al.
·
Open Forum Infectious Diseases
PDF
1082. Real-World Experience with Omadacycline for Nontuberculous Mycobacterial Infections: A Multicenter Evaluation
2021
·
Taylor Morrisette
, Sara Alosaimy
, et al.
·
Open Forum Infectious Diseases
Show more works
View as search
Works count:
8
Citation count:
60
H-index:
3
I10-index:
3
Year
Topic
Type